Sign in
Active, not recruitingNo phase

SCOPE-CLI: Shifting Care and Outcomes for Patients With Endangered Limbs

Key facts

Who runs it
Yale University
Where
New Haven, United StatesSee the site
Trial code
Status
Active, not recruiting
People taking part
458 people enrolled
Started
11 Aug 2021
Expected to end
Sept 2028
Type of study
Observational
Record updated
20 October 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • All race/ethnicity categories, English speaking, men and women
  • Patient presents with current (within 30 days) Rutherford Class 4, 5, or 6
  • Age ≥18 years
  • Supported by any of the following diagnostic evidence:; Rutherford Classification 4 or ischemic rest pain and/or resting ankle pressure <50mmHg, flat or barely pulsatile ankle or metatarsal PVR or toe pressure <40mmHg; Rutherford Classification 5 or minor tissue loss; non-healing ulcer, focal gangrene with diffuse pedal ischemia resting ankle pressure <50mmHg ankle or metatarsal PVR flat or barely pulsatile or toe pressure <40mmHg; Rutherford Classification 6 or major tissue loss: extending above transmetatarsal level, functional foot no longer salvageable, resting ankle pressure <50mmHg ankle or metatarsal PVR flat or barely pulsatile or toe pressure <40mmHg; CLI related ICD 10 code (reason for admission or indication for procedure); SPP < 50 mmHg; TCPO2 < 50 mmHg; Angiographic evidence no straight line to foot or greater than 70% stenosis in all 3 lower extremity arteries (AT, PT, peroneal); ABI* ≤ 0.90; non-compressible ABI ≥ 1.40 AND TBI ≤ 0.70; TBI* ≤ 0.70

Who cannot take part

  • Acute limb ischemia
  • Unable to provide written informed consent
  • Currently a prisoner (identified at time of enrollment)

Where in United States

  • Yale New Haven HealthNew Haven, United States

About the trial

What the trial wants to find out

A research project capturing experiences of patients with critical limb threatening ischemia, with the ultimate goal of setting new standards for diagnosing, describing detailed patient-centered outcomes, and evaluating the variability in therapeutic approaches and their association with outcomes.

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
SCOPE-CLI: Shifting Care and Outcomes for Patients With Endangered Limbs - Critical Limb Ischemia
Publications
Record updated
20 October 2025